I-Flow's InfuSystem joins HAPC:
This article was originally published in Clinica
Chemotherapy infusion pump service provider InfuSystem has taken on a new name, InfuSystem Holdings, following the closing of its sale to HAPC. New York-based HAPC had initially agreed to buy InfuSystem from the latter's parent company, I-Flow, in October 2006 for $140m, but the sale price was reduced to $100m in September this year to reflect changes in the economic environment and the marketplace, said the companies (see Clinica No 1274, p 11). I-Flow will also receive $12m in milestones as part of the deal. The Lake Forest, California firm had bought a 15% stake in HAPC in October to push through shareholder approval of the transaction.